Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01245647 · ClinicalTrials.gov registry record · Phase 2
Will Having Alcohol Treatment Improve Functioning?
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT01245647 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 19 participants.
The verdict
NCT01245647, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of the study is to find out if a medication,naltrexone is helpful for HIV-infected women who sometimes drink too much. The study will try to find out whether women like the medication, whether the medication helps them cut back on their drinking, and whether it helps improve their overall health. Naltrexone has not been used widely among people who are engaged in less severe drinking and in primary health care settings. Therefore, the investigators would like to determine whether it is helpful among women who sometimes drink 4 or more drinks per occasion or 7 or more drinks per week. The investigators hypothesize that by taking naltrexone, women with hazardous drinking pattern will reduce their drinking which in turn will improve their medication adherence, improve their health and quality of life.
Interventions
- DRUG Naltrexone, 50mg, once per day for 4 months
- OTHER Sugar pill, 50mg, once per day for 4 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01245647
The ClinicalTrials.gov registry entry for NCT01245647 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Naltrexone, 50mg, once per day for 4 months is the first listed.
NCT01245647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01245647 about?
NCT01245647 is a clinical study titled "Will Having Alcohol Treatment Improve Functioning?". The purpose of the study is to find out if a medication,naltrexone is helpful for HIV-infected women who sometimes drink too much. The study will try to find out whether women like the medication, whether the medication helps them cut back on their drinking, and whether it helps improve their overal...
What is the current status of trial NCT01245647?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2010-11. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01245647?
The interventions under investigation include: Naltrexone, 50mg, once per day for 4 months (DRUG), Sugar pill, 50mg, once per day for 4 months (OTHER).
Who is sponsoring clinical trial NCT01245647?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.